Feb 13 (Reuters)-
Kohjin Bio Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2025 Dec 31, 2024 Mar 31, 2026
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 3.79 3.92 4.97
(-3.4 pct) (+10.7 pct) (-4.5 pct)
Operating 387 mln 675 mln 464 mln
(-42.6 pct) (+82.0 pct) (-53.1 pct)
Recurring 385 mln 740 mln 467 mln
(-48.0 pct) (+86.2 pct) (-56.1 pct)
Net 279 mln 516 mln 335 mln
(-45.9 pct) (+149.6 pct) (-57.8 pct)
EPS 54.71 yen 102.95 yen 65.65 yen
Ann Div 24.00 yen 10.00 yen
-Q2 div NIL NIL
-Q4 div 24.00 yen 10.00 yen
NOTE - Kohjin Bio Co., Ltd..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=177A.T